Latest news Venous Archives

Editor's Pick Interviews Editors Pick Homepage Learning Areas Venous Editors Pick Venous Venous Interviews Latest news Venous Video Types

COVID-19 will have “massive long-term impact” on treatment of venous disease patients

Manj Gohel (Cambridge, UK) is joined by a host of venous experts including Beverley Hunt (London, UK), Stephen Black (London, UK) and Ian Franklin (London, UK) to look at the long-term impact of the COVID-19 crisis on the treatment of chronic venous...

Venous Webinars Editor's Pick Editors Pick Homepage Learning Areas Editors Pick Venous Latest news Venous Venous

Telehealth ‘will change the future of venous practice’ post COVID-19

Six venous specialists, Manj Gohel (Cambridge, UK), Ian Franklin (London, UK) Alun Davies (London, UK), Sriram Narayanan (Singapore), Raghu Kolluri (Columbus, USA) and Stephen Black (London, UK) discuss the role of telehealth during the COVID-19...

VEITH 2019 Editor's Pick Interviews Learning Areas Events Editors Pick Venous Venous Interviews Latest news Venous Venous Video Types

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

Kathleen Gibson (Bellevue, USA) put the five-year data from the VeClose study, which looked at the treatment of patients with venous reflux in the great saphenous vein (GSV) with either the VenaSeal closure system (Medtronic) or radiofrequency...

COVID-19 will have “massive long-term impact” on treatment of venous disease patients

Telehealth ‘will change the future of venous practice’ post COVID-19

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

Latest news Venous

COVID-19 will have “massive long-term impact” on treatment of venous disease patients

Telehealth ‘will change the future of venous practice’ post COVID-19

VeClose five-year data give confidence about long-term durability of VenaSeal treatment

VEITH 2019: Abre venous stent study baseline demographic data presented

Thrombosis is major by-product of infection with COVID-19, but evidence to back full dose anticoagulation lacking

Early intervention for leg ulcers a global “golden opportunity” to improve care and save on costs

LINC 2020: IVUS helps to reduce radiation exposure “significantly” for patients undergoing venous stenting

VIVA 2019: Competition in the venous stenting space “will ultimately benefit patients”

New trial planned to rigorously test catheter-directed thrombolysis for submassive PE treatment

VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but other factors at play as well

SeCure trial data show ablation of incompetent perforator veins benefits patients

Randomised controlled study of EVLA and Foam in the SSV-a study from SFP (Fovelass Study) – Tuesday, 24th April

Podium 1st: The EVRA trial – CX 2018

Five years of deep venous stenting-where next? – CX 2018